PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Sahajanand Medical Technologies Limited

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (5)

Compared with Healthcare companies in India.

P/E ratio

60.4

Investors pay ₹60.4 for every ₹1 of Sahajanand Medical Technologies Limited's yearly profit, higher than 77% of Healthcare companies in India.

P/B ratio

5.68

The share price is 5.68 times Sahajanand Medical Technologies Limited's book value per share, higher than 64% of Healthcare companies in India.

Market cap

₹4,174 Cr

The total market value of all of Sahajanand Medical Technologies Limited's shares at today's price (share price × number of shares), smaller than 52% of Healthcare companies in India. PosiCap size class: Mini Cap.

Return on equity (ROE)

10.7%

Sahajanand Medical Technologies Limited earned 10.7% on its shareholders' money over the last year, lower than 61% of Healthcare companies in India.

Dividend yield

None

Sahajanand Medical Technologies Limited does not currently pay a dividend.

Questions

What is Sahajanand Medical Technologies Limited's P/E ratio?

Investors pay ₹60.4 for every ₹1 of Sahajanand Medical Technologies Limited's yearly profit, higher than 77% of Healthcare companies in India.

What is Sahajanand Medical Technologies Limited's return on equity?

Sahajanand Medical Technologies Limited earned 10.7% on its shareholders' money over the last year, lower than 61% of Healthcare companies in India.

Does Sahajanand Medical Technologies Limited pay a dividend?

No. Sahajanand Medical Technologies Limited does not currently pay a dividend.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.